Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Cobenfy

Neuroscience

Neuroscience Today—April 1, 2026

This week’s Neuroscience update highlights regulatory progress in rare…

Neuroscience

Neuroscience Video Recap—December 10, 2025

This biweekly Neuroscience video recap highlights major regulatory wins,…

Neuroscience

Neuroscience Today — December 10, 2025

This week’s Neuroscience update features major regulatory decisions, strong…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

AI in Healthcare and Digital Health Today—April 20, 2026
Lucid Diligence Brief: 10x Genomics launches Atera Platform
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: STORM Therapeutics $56 million Series C for Phase II in Sarcoma
Respiratory Today—April 17, 2026

Tags

AI-native clinical development AMXT 1501 Barostim Baseimmune Chronic disease mortality conduction-system pacing cost reduction CS014 CUF Dersimelagon DIPS Arena Emboline Enzalutamide FDA Digital Health Advisory FG001 FIGO Gazyvaro Glanzmann Thrombasthenia GLP-1 Receptor Agonists glycosylation gout flares Health AI Health Link Jaypirca live biotherapeutic product Merck Animal Health MicroRNAs naxtarubicin OCALIVA orexin Pediatric Cancers Pfizer China PPMS QRX003 ralinepag Receptor.AI Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical TG Therapeutics Transgene UPATHLN Ver-A-T1D

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

AI in Healthcare and Digital Health Today—April 20, 2026
Lucid Diligence Brief: 10x Genomics launches Atera Platform
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: STORM Therapeutics $56 million Series C for Phase II in Sarcoma
Respiratory Today—April 17, 2026

TAGS

AI-native clinical development AMXT 1501 Barostim Baseimmune Chronic disease mortality conduction-system pacing cost reduction CS014 CUF Dersimelagon DIPS Arena Emboline Enzalutamide FDA Digital Health Advisory FG001 FIGO Gazyvaro Glanzmann Thrombasthenia GLP-1 Receptor Agonists glycosylation gout flares Health AI Health Link Jaypirca live biotherapeutic product Merck Animal Health MicroRNAs naxtarubicin OCALIVA orexin Pediatric Cancers Pfizer China PPMS QRX003 ralinepag Receptor.AI Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical TG Therapeutics Transgene UPATHLN Ver-A-T1D

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy